Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MDK-703 |
Trade Name | |
Synonyms | MDK 703|MDK703 |
Drug Descriptions |
MDK-703 is an Fc-peptide fusion that activates the IL-7 receptor, potentially leading to enhanced antitumor immune response (Cancer Res 2022;82(12_Suppl):Abstract nr 2066). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
MDK-703 | MDK-703 | 0 | 1 |
MDK-703 + unspecified immune checkpoint inhibitor | MDK-703 unspecified immune checkpoint inhibitor | 0 | 1 |